Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Santen Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 14
Asset Purchase 14
Santen Pharma Acquires Remaining Portfolio of Ophthalmology Products from Merck 14
Venture Financing 16
RetroSense Therapeutics Raises USD6 Million in Series B Financing Round 16
TearSolutions Raises USD3 Million in Series A Financing Round 17
Clearside Biomedical Raises USD16 Million in Series B Venture Financing 18
Clearside Biomedical Raises US$8 Million In Venture Financing 20
Partnerships 22
Durect Enters into Licensing Agreement with Santen Pharma 22
PeptiDream Enters into Co-Development Agreement with Santen Pharma 23
Aequus Pharma Enters into Agreement with Santen 24
Santen Enters into Research Agreement with twoXAR 25
Santen Pharma Enters into Research Agreement with Riken and Foundation for Biomedical Research and Innovation 26
Santen Pharma to Enter into Agreement with University College London 27
Santen Pharma and Chongqing Kerui Pharma Form Joint Venture 28
Santen Expands Research Agreement with Clearside Biomedical 29
Santen Pharma Enters into Co-Development Agreement with SERI 30
Santen Pharma and Singapore Eye Research Institute Expand Agreement 31
Tracon Pharma Enters Into Co-Development Agreement With Santen Pharma 32
Santen Enters Into Research Agreement With Clearside Biomedical 34
Aqua Therapeutics Enters into Research Agreement with Santen Pharma 35
Regeneron Pharma And Bayer Yakuhin Enter Into Co-Promotion Agreement With Santen Pharma For Eylea 36
Licensing Agreements 38
Santen Pharma Enters into Licensing Agreement with NTC 38
Santen Pharma Enters into Licensing Agreement with Ono Pharma 39
Parion Sciences Enters into Licensing Agreement with Santen Pharma For P-321 40
Santen Extends Licensing Agreement with Eupharmed to Distribute Cationorm 41
Santen Pharma Enters into Licensing Agreement with Oak Pharma 42
Santen Pharma And Eisai Enter Into Option Agreement For Ophthalmic Drugs 43
Asset Transactions 44
Hyperion Pharma Acquires Anti-Rheumatic Pharma Business of Santen Pharma for USD375 Million 44
R-Tech Ueno Acquires Rights to DE-105 from Santen Pharma 45
Akorn Acquires Betimol, Opthalmic Drug, From Santen 46
Santen Pharmaceutical Co Ltd – Key Competitors 47
Santen Pharmaceutical Co Ltd – Key Employees 48
Santen Pharmaceutical Co Ltd – Locations And Subsidiaries 50
Head Office 50
Other Locations & Subsidiaries 50
Recent Developments 53
Financial Announcements 53
Nov 07, 2018: Santen reports consolidated results for Q2 fiscal 2018 53
May 09, 2018: Santen Reports Fiscal 2017 Consolidated Performance 54
Nov 01, 2017: Santen Consolidated Results for Q2 Fiscal 2017 55
Aug 01, 2017: Santen Pharma Reports Revenue Of JPY55.95 Billion In Q1 Fiscal 2018 56
May 10, 2017: Santen Reports Fiscal 2016 Consolidated Performance 57
Feb 07, 2017: Santen Pharma Reports Revenue Of JPY150.7 Billion In Nine Months Ended December 31, 2016 58
Corporate Communications 59
Sep 12, 2018: Santen Pharmaceutical announce personnel changes of representative Director of the Board 59
Jul 17, 2018: Santen Donates to Japan Flood and Landslide Relief Efforts 60
Mar 01, 2018: Luis Iglesias Promoted to Head of Santen EMEA 61
Feb 20, 2018: Santen Announces Appointment of New President 62
Jul 18, 2017: Santen Donates to Northern Kyushu Area Disaster Relief Efforts 63
May 10, 2017: Santen: Notice of Board of Director and Corporate Auditor Nominations 64
Mar 15, 2017: Santen Pharmaceutical: Notice of Corporate Officer Appointments 66
Product News 68
07/26/2017: Santen Receives Positive CHMP Opinion in Europe for Ciclosporin eye drops for the Treatment of Paediatric Patients with Severe Vernal Keratoconjunctivitis 68
07/21/2017: New medicine for rare form of eye allergy in children and teenagers 69
07/10/2018: Santen Pharmaceutical : Receives Marketing Authorisation from the European Commission for DE-076C (Verkazia) as an Orphan Medicinal Product 70
Other Significant Developments 71
Jun 04, 2018: Santen Announces Medium-Term Plan (MTP2020) 71
Feb 20, 2018: Santen Pharmaceutical to Leverage Medidata Edge CTMS to Drive Future Growth in Ophthalmic Clinical Development 72
Apr 07, 2017: Santen Announces Strategic Investment in Regenerative Patch Technologies 73
Appendix 74
Methodology 74
About GlobalData 74
Contact Us 74
Disclaimer 74
Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Santen Pharmaceutical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 9
Santen Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Santen Pharma Acquires Remaining Portfolio of Ophthalmology Products from Merck 14
RetroSense Therapeutics Raises USD6 Million in Series B Financing Round 16
TearSolutions Raises USD3 Million in Series A Financing Round 17
Clearside Biomedical Raises USD16 Million in Series B Venture Financing 18
Clearside Biomedical Raises US$8 Million In Venture Financing 20
Durect Enters into Licensing Agreement with Santen Pharma 22
PeptiDream Enters into Co-Development Agreement with Santen Pharma 23
Aequus Pharma Enters into Agreement with Santen 24
Santen Enters into Research Agreement with twoXAR 25
Santen Pharma Enters into Research Agreement with Riken and Foundation for Biomedical Research and Innovation 26
Santen Pharma to Enter into Agreement with University College London 27
Santen Pharma and Chongqing Kerui Pharma Form Joint Venture 28
Santen Expands Research Agreement with Clearside Biomedical 29
Santen Pharma Enters into Co-Development Agreement with SERI 30
Santen Pharma and Singapore Eye Research Institute Expand Agreement 31
Tracon Pharma Enters Into Co-Development Agreement With Santen Pharma 32
Santen Enters Into Research Agreement With Clearside Biomedical 34
Aqua Therapeutics Enters into Research Agreement with Santen Pharma 35
Regeneron Pharma And Bayer Yakuhin Enter Into Co-Promotion Agreement With Santen Pharma For Eylea 36
Santen Pharma Enters into Licensing Agreement with NTC 38
Santen Pharma Enters into Licensing Agreement with Ono Pharma 39
Parion Sciences Enters into Licensing Agreement with Santen Pharma For P-321 40
Santen Extends Licensing Agreement with Eupharmed to Distribute Cationorm 41
Santen Pharma Enters into Licensing Agreement with Oak Pharma 42
Santen Pharma And Eisai Enter Into Option Agreement For Ophthalmic Drugs 43
Hyperion Pharma Acquires Anti-Rheumatic Pharma Business of Santen Pharma for USD375 Million 44
R-Tech Ueno Acquires Rights to DE-105 from Santen Pharma 45
Akorn Acquires Betimol, Opthalmic Drug, From Santen 46
Santen Pharmaceutical Co Ltd, Key Competitors 47
Santen Pharmaceutical Co Ltd, Key Employees 48
Santen Pharmaceutical Co Ltd, Other Locations 50
Santen Pharmaceutical Co Ltd, Subsidiaries 51
List of Figures
Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Santen Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 10